Pennsylvania's House of Representatives voted unanimously to pass a bill banning synthetic kratom products statewide, responding to dozens of deaths and a wave of poison control calls tied to the increasingly common gas-station drug. The Kratom Standards, Labeling and Consumer Protection Act, known as House Bill 2657, now moves to the state Senate for further consideration.
The vote came on October 13, as reported by FOX43, with the legislation introduced by Reps. Bridget Kosierowski of Lackawanna County, Jim Prokopiak of Bucks County, Kyle Donahue of Lackawanna County, and Dan Frankel of Allegheny County. Prokopiak said Pennsylvania families have been negatively affected by kratom, often without realizing how addictive it can be, and that “Pennsylvanians deserve protection from these potentially deadly products being sold in our communities,” adding that the bill “eliminates the potent synthetic kratom products that are the most dangerous” and establishes standards that “will help ensure greater transparency for consumers,” according to the same report.
Behind the push is a grim set of numbers. Pennsylvania has recorded 33 deaths since 2025 in which kratom was a contributing factor, according to Department of Health statistics cited by the Pennsylvania House Democratic Caucus. The same data shows 106 kratom-related cases logged by poison centers in the first half of 2026, 41 of which specifically involved the concentrated compound 7-hydroxymitragynine, or 7-OH. Multiple cases required naloxone to reverse an overdose.
Where the Bill Draws the Line
HB 2657 does not ban kratom outright. Instead, it would create a statutory framework for how the plant-based product is sold, distributed, and quality-controlled across the state, allowing registered retailers to sell natural-leaf kratom only to adults 21 and older. Packaging would be required to list the manufacturer's name and address, carry a warning that the product has not been evaluated by the FDA, and make no medical claims, per the bill text.
The legislation defines illegal synthetic products specifically: any kratom item with a 7-OH level above 0.05% by dry weight, any mitragynine pseudoindoxyl, or any synthetically derived alkaloids would be banned, according to the bill text filed with the Pennsylvania General Assembly. Natural kratom leaf contains only trace amounts of 7-OH, which is the distinction regulators are trying to protect. Natural kratom sales would also become subject to the state's tobacco products tax, with revenue flowing into a newly created Kratom Regulatory Fund to pay for Department of Health enforcement, under the amended version of the bill.
Enforcement Beyond the State Agency
The bill designates retail violations as deceptive trade practices under Pennsylvania's Unfair Trade Practices and Consumer Protection Law, allowing injured consumers to sue for damages and legal fees and providing for local-government investigation and enforcement.
That local enforcement push has already begun outpacing Harrisburg. In October, district attorneys in Bucks, Chester, and Berks counties asked Pennsylvania Secretary of Health Dr. Debra Bogen to use emergency administrative authority to classify 7-OH as a state controlled substance ahead of full legislative enactment, according to the Pennsylvania Capital-Star.
Medical and Federal Backing
The medical community has lined up behind the bill. The Pennsylvania Society of Addiction Medicine issued formal support for HB 2657 in September, stating that addiction specialists across the state are treating a growing number of patients for kratom poisoning, dependence, and severe withdrawal tied to unregulated smoke shop and gas station sales. The organization's letter emphasized that 7-OH behaves as an atypical opioid with significant potential for addiction, according to the Pennsylvania Society of Addiction Medicine.
Federal regulators are moving on a parallel track. On October 9, the U.S. Department of Justice and the Drug Enforcement Administration issued updated notices of intent to temporarily schedule related compounds as Schedule I controlled substances. The notices adopt federal health guidelines targeting products exceeding 1 milligram per gram or milliliter, or a 100-to-1 mitragynine-to-7-OH ratio. That action builds on earlier intervention: the FDA has also sent warning letters to companies.
The kratom industry itself has largely embraced the synthetic-versus-natural distinction driving these efforts. The American Kratom Association held press briefings at the U.S. Capitol in October discussing federal action targeting concentrated synthetic 7-OH while pushing for continued access to regulated whole-leaf botanical kratom, according to StreetInsider. The association has backed similar Kratom Consumer Protection Acts in other states to preserve a legal market for natural leaf.
Part of a Broader National Pattern
Pennsylvania's effort fits a pattern playing out nationwide. Twenty-four other states regulate kratom products, reflecting a shift away from outright prohibition toward consumer-protection standards for botanical leaf.
Other states also regulate kratom products. Whether Pennsylvania's bill ultimately changes what's on shelves will hinge on more than Tuesday's vote. Its impact depends on Senate passage, executive enactment, and the Department of Health's capacity to actually enforce the new rules and keep illicit synthetic extracts out of retail stores.
